Endogenous interleukin-10 protects against hepatic steatosis but does not improve insulin sensitivity during high-fat feeding in mice

被引:69
作者
den Boer, Marion A. M.
Voshol, Peter J.
Schroder-van der Elst, Janny P.
Korsheninnikova, Elena
Ouwens, D. Margriet
Kuipers, Folkert
Havekes, Louis M.
Romijn, Johannes A.
机构
[1] Leiden Univ, Med Ctr, Dept Endocrinol & Metab, NL-2333 ZA Leiden, Netherlands
[2] Leiden Univ, Med Ctr, Dept Mol Cell Biol, NL-2333 ZA Leiden, Netherlands
[3] Leiden Univ, Med Ctr, Dept Cardiol, NL-2333 ZA Leiden, Netherlands
[4] Univ Groningen, Med Ctr, Dept Pediat, NL-9700 AB Groningen, Netherlands
[5] Netherlands Org Appl Sci Res Qual Life, NL-2333 CK Leiden, Netherlands
关键词
D O I
10.1210/en.2006-0417
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Several studies have demonstrated an association in humans between plasma levels or production capacity of the antiinflammatory cytokine IL-10 and insulin sensitivity. The aim of our study was to investigate the protective role of endogenous IL-10 availability in the development of diet-induced insulin resistance. We compared parameters of glucose and lipid metabolism between IL-10(-/-) mice and wild-type (wt) mice fed a high-fat diet for 6 wk. This diet has previously been shown to induce steatosis and insulin resistance. After 6 wk on the high-fat diet, no differences in body weight, basal metabolism ( measured by indirect calorimetry), or plasma levels of glucose, triglycerides, or cholesterol were observed between IL10(-/-) and wt mice. Nonetheless, in IL-10(-/-) mice, plasma free fatty acid levels were 75% increased compared with wt mice after overnight fasting (P < 0.05). In addition, hepatic triglyceride content was 54% increased in IL- 10(-/-) mice ( P < 0.05). During a hyperinsulinemic euglycemic clamp, no differences were observed in whole-body or hepatic insulin sensitivity between both groups. We conclude that basal IL-10 production protects against hepatic steatosis but does not improve hepatic or whole-body insulin sensitivity, during high-fat feeding.
引用
收藏
页码:4553 / 4558
页数:6
相关论文
共 34 条
[1]
Association of multiple risk factors and insulin resistance with increased prevalence of asymptomatic coronary artery disease by an electron-beam computed tomographic study [J].
Arad, Y ;
Newstein, D ;
Cadet, F ;
Roth, M ;
Guerci, AD .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2001, 21 (12) :2051-2058
[2]
BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
[3]
Association between measures of insulin sensitivity and circulating levels of interleukin-8, interleukin-6 and tumor necrosis factor-α.: Effect of weight loss in obese men [J].
Bruun, JM ;
Verdich, C ;
Toubro, S ;
Astrup, A ;
Richelsen, B .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2003, 148 (05) :535-542
[4]
Interleukin-10 deficiency increases atherosclerosis, thrombosis, and low-density lipoproteins in apolipoprotein E knockout mice [J].
Caligiuri, G ;
Rudling, M ;
Ollivier, V ;
Jacob, MP ;
Michel, JB ;
Hansson, GK ;
Nicoletti, A .
MOLECULAR MEDICINE, 2003, 9 (1-2) :10-17
[5]
Hepatic steatosis: A mediator of the metabolic syndrome. Lessons from animal models [J].
den Boer, M ;
Voshol, PJ ;
Kuipers, F ;
Havekes, LM ;
Romijn, JA .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (04) :644-649
[6]
DERTHUSEN JH, 2001, FASEB J, V16, P2730
[7]
Association of low interleukin-10 levels with the metabolic syndrome in obese women [J].
Esposito, K ;
Pontillo, A ;
Giugliano, F ;
Giugliano, G ;
Marfella, R ;
Nicoletti, G ;
Giugliano, D .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (03) :1055-1058
[8]
FIORENTINO DF, 1991, J IMMUNOL, V147, P3815
[9]
FIORENTINO DF, 1991, J IMMUNOL, V146, P3444
[10]
Elevated plasma interleukin-18 is a marker of insulin-resistance in type 2 diabetic and non-diabetic humans [J].
Fischer, CP ;
Perstrup, LP ;
Berntsen, A ;
Eskildsen, P ;
Pedersen, BK .
CLINICAL IMMUNOLOGY, 2005, 117 (02) :152-160